POSTER SESSION III Tuesday, March 4, 2008   —  9:30 AM - 12:00 Noon Convention Center Exhibit Hall A Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... GYNECOLOGIC PATHOLOGY Poster# Title and Authors Itinerary Planner 140 HER-2/neu Receptor Gene Amplification and Protein Expression in Endometrial Serous Cancer: A Comprehensive Tissue Microarray Study (1047) ML Xu, P Schwartz, P Hui - Yale-New Haven Hospital, New Haven, CT Add 141 Overexpression of Heat Shock Protein (HSP27, HSP70 and HSP90) in Uterine Papillary Serous Carcinoma (888) BA Adeagbo, T Goldsmith, S Ghamande, K Gu, P Ramalingam - Medical College of Georgia, Augusta, GA; University of Nebraska, Nebraska, NE Add 142 Immunohistochemical Profile of Atypical Endometrial Syncytial Papillary & Eosinophilic Metaplasia Versus Serous Carcinoma (971) RK Malhotra, S Qiu, M Eltorky - University of Texas Medical Branch, Galveston, TX Add 143 Clinical and Pathologic Findings in Women with Endometrial Carcinoma: Does the Pap Test Matter? (940) KN Gilbert-Lewis, VJ Schnadig, EM Betancourt - University of Texas Medical Branch, Galveston, TX Add 144 Diagnostic Yield of Cervicovaginal Samples in Patients with Uterine Serous Papillary Carcinomas (936) MT Garcia, E Jimenez, JM Pearson, P Ganjei-Azar - University of Miami / Jackson Memorial Hospital, Miami, FL Add 145 Protein Kinase CK2 Plays a Role in Apoptosis Resistance in Endometrial Carcinoma, by Regulating FLIP (991) J Pallares, X Dolcet, D Llobet, N Eritja, X Matias-Guiu - Hospital U Arnau de Vilanova, Lleida, Spain Add 146 Morphoproteomic Evidence of an Activated and Overexpressed mTOR Pathway in Endometrial Carcinoma (1031) ML Stanton, ME Rodriguez, RE Brown, X Duan - The University of Texas Medical School at Houston, Houston, TX Add 147 Epigenetic Mechanism Is Responsible for Downregulation of Prostate-Specific Membrane Antigen in a Subset of Endometrial Carcinomas (941) D Higgs, D Smiraglia, K Odunsi, F Herrmann, P Mhawech-Fauceglia - Roswell Park Cancer Institute, Buffalo, NY; HUG, Geneva, Switzerland Add 148 Endometrial Carcinoma - Is the Staging System Accurate? (891) H Arabi, R Ali-Fehmi, S Bandyopadhyay, L Fathalla, D Thirabanjasak, A Munkarah, R Morris, E Silva - Wayne State University, Detroit, MI; MD Andeson Cancer Center, Houston, TX Add 149 Epithelial Mesenchymal Transition Regulator, Snail: Expression in Uterine Carcinosarcoma (951) NE Joseph, T Stricker, A Montag - University of Chicago, Chicago, IL Add 150 The Polycomb Protein, Enhancer of Zeste (Homolog) 2, Is Consistently Expressed in Uterine Carcinosarcomas (952) NE Joseph, TP Stricker, AG Montag - University of Chicago, Chicago, IL Add 151 Lymphatic Microvessel Density as a Prognostic Marker in Endometrial Carcinosarcoma (1016) RS Saad, N Ismiil, Z Ghorab, JF Silverman, S Nofech-Mozes, MA Khalifa - Sunnybrook Health Science Center, Toronto, ON, Canada; Allegheny General Hospital, Pittsburgh, PA Add 152 Diagnostic Use of Nuclear beta-Catenin Expression in Assessing Endometrial Stromal Tumors (953) CK Jung, JH Jung, YS Lee, ES Jung, YJ Choi, KY Lee - College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Add 153 Uterine Tumors Resembling Ovarian Sex Cord Tumors Lack the JAZF1-JJAZ1 Gene Fusion Commonly Seen in Endometrial Stromal Tumors (1030) N Staats, G Kuhlmann, JJ Garcia, WG McCluggage, M De Nictolis, RA Soslow, AJ Iafrate, E Oliva - Massachusetts General Hospital, Boston, MA; Memorial Sloan Kettering Cancer Center, New York, NY; Royal Group of Hospitals Trust, Belfast, Northern Ireland, United Kingdom; Universita' Degli Studi Di Ancona, Ancona, Italy Add 154 Histopathologic Features and Clinical Outcomes of Uterine Leiomyomas in Pregnancy (1032) ML Stanton, MT Deavers, A Malpica, X Duan - The University of Texas Medical School at Houston and MD Anderson Cancer Center, Houston, TX Add 155 Utility of the Mitosis Marker Anti-Phosphohistone H3 in Precise and Rapid Evaluation of Mitotic Index in Leiomyomas with Bizarre Nuclei (1037) G Toledo, WB Growdon, MLD Palmeri, BR Rueda, E Oliva - Massachusetts General Hospital, Boston, MA Add 156 Overexpression of REG Gamma in Uterine Leiomyosarcoma (1045) J Xiao, X Li, PK Johnston, M Stanton, M Rodriguez, R Brown, X Duan - he University of Texas Houston Medical School, Houston, TX; Baylor College of Medicine, Houston, TX Add 157 Regulation of HMGA2 Expression by let-7 microRNAs in Uterine Leiomyosarcoma (1026) GZ Shi, K Mittal, P Yi, J Laser, P Lee, E Hernando, JJ Wei - New York University, New York, NY Add 158 Morphoproteomic Evidence of Constitutively Activated and Overexpressed mTOR Pathway in Uterine Leiomyosarcomas vs STUMP, Leiomyoma and Myometrium (1007) ME Rodriguez, ML Stanton, X Duan, JH Connelly, RE Brown - University of Texas Medical School, Houston, TX; St. Luke's Episcopal Hospital, Houston, TX Add 159 Adenosarcoma with Sarcomatous Overgrowth, a Clinicopathologic Study of 37 Cases (927) ED Euscher, A Malpica - M.D. Anderson Cancer Center, Houston, TX Add 160 Undifferentiated Uterine Sarcomas: A Diagnosis of Exclusion with Apparent Prognostic Significance (1029) RA Soslow, K Garg, M Guile, MM Leitao, Jr. - MSKCC, New York, NY Add